Skip to main content

Month: January 2022

Foodland Chairman Jenai Wall to Not Stand for Re-Election to First Hawaiian Board

HONOLULU, Jan. 20, 2022 (GLOBE NEWSWIRE) — First Hawaiian, Inc. (NASDAQ: FHB) announced today that Foodland Chairman and CEO Jenai S. Wall will not be standing for re-election as a director of First Hawaiian Inc. (FHI) or First Hawaiian Bank (FHB) at the company’s upcoming annual stockholder’s meeting on April 20, 2022. Wall currently serves on the Board’s Compensation Committee and Risk Committee. Her 27 years of service began when she joined the First Hawaiian Bank board in 1995 and continued with her appointment to the FHI Board in August 2018. “Jenai has been a tremendous board member, providing wise counsel with her extensive business and leadership experience,” said Bob Harrison, First Hawaiian Chairman, President and CEO. “We want to thank her for years of service to our board and the many contributions she has made...

Continue reading

ISC Provides Corporate Update

REGINA, Saskatchewan, Jan. 20, 2022 (GLOBE NEWSWIRE) — Information Services Corporation (TSX:ISV) (“ISC” or the “Company”) today announced that Ms. Karyn Brooks has stepped down from its Board of Directors (the “Board”), effective immediately. The Company thanks Ms. Brooks for her significant contributions to the Board and as a member of ISC’s Audit Committee. Joel Teal, Chair of ISC commented, “On behalf of the Board of Directors, I would like to thank Karyn for her unwavering commitment to ISC since joining the Board in 2016. Her professionalism and wise counsel will be missed around the Board table.” Shawn Peters, President & CEO designate, added, “As a member of the Audit Committee, Karyn was a valuable resource during my time as Executive Vice President & CFO. Her commitment to strong financial...

Continue reading

Bluewater Acquisition Corp. Announces TSXV Conditional Acceptance of Qualifying Transaction and Extension of Deadline to Complete Qualifying Transaction

Not for distribution to U.S. news wire services or for dissemination in the United States. CALGARY, Alberta, Jan. 20, 2022 (GLOBE NEWSWIRE) — Bluewater Acquisition Corp. (“BAQ”) (TSXV: BAQ.P) is pleased to announce that it has received conditional acceptance from the TSX Venture Exchange (the “TSXV”) for the closing of its proposed qualifying transaction (the “Qualifying Transaction”) with VM Agritech Limited (“VMA”). Further to its news release dated October 26, 2021, BAQ entered into a share exchange agreement (the “Share Exchange Agreement”) with VMA and its shareholders, with respect to the acquisition by BAQ of all the issued and outstanding share capital of VMA. Upon completion of the acquisition contemplated in the Share Exchange Agreement, VMA will become a wholly-owned subsidiary of BAQ, and it is anticipated that the...

Continue reading

Heartland Media Acquisition Corp. Announces Pricing of $175 Million Initial Public Offering

ATLANTA, Jan. 20, 2022 (GLOBE NEWSWIRE) — Heartland Media Acquisition Corp. (the “Company”) today announced the pricing of its initial public offering of 17,500,000 units, at a price of $10.00 per unit. The units will be listed on the New York Stock Exchange (“NYSE”) and trade under the ticker symbol “HMA.U” beginning on January 21, 2022. Each unit consists of one share of Class A common stock and one-half of one redeemable warrant, with each whole warrant exercisable to purchase one share of Class A common stock at a price of $11.50 per share. Only whole warrants will be exercisable. Once the securities comprising the units begin separate trading, the shares of Class A common stock and warrants are expected to be listed on the NYSE under the symbols “HMA” and “HMA.WS,” respectively. The offering is expected to close on January...

Continue reading

Clover’s Final SPECTRA Phase 2/3 Clinical Trial Efficacy Data Is Published in The Lancet

CHENGDU, China, Jan. 21, 2022 (GLOBE NEWSWIRE) — Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates, today announced that final efficacy data from SPECTRA, a global Phase 2/3 clinical trial evaluating the efficacy, safety, and immunogenicity of its COVID-19 vaccine candidate, SCB-2019 (CpG 1018/Alum), has been published in the peer-reviewed journal, The Lancet. The paper, ‘Efficacy of the adjuvanted subunit protein Covid-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial,’ may be accessed here. SCB-2019 (CpG 1018/Alum) achieved the primary efficacy endpoint and secondary efficacy endpoints. The COVID-19 vaccine candidate also demonstrated 100% efficacy against severe...

Continue reading

Sintana Announces Amendment to Proposed Acquisition of Petroleum Exploration License Interests in Namibia

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA TORONTO, Jan. 20, 2022 (GLOBE NEWSWIRE) — Sintana Energy Inc. (TSXV: SEI) (the “Company” or “Sintana”) announces today that it has entered into an amendment agreement dated January 20, 2022 (the “Amendment Agreement”) with respect to its previously announced proposed acquisition (the “Acquisition”) of a 49% interest in all of the issued and outstanding shares of Inter Oil (Pty) Ltd. (“Inter Oil”) from Grisham Assets Corp. (“Grisham”). As previously announced, Inter Oil indirectly holds a strategic portfolio of onshore and offshore petroleum exploration license interests in Namibia. The consideration for the Acquisition consists of an aggregate of 34,933,333 common shares of the Company and a cash payment in the amount of US$4,000,000...

Continue reading

Pretivm Announces Shareholder Approval of Plan of Arrangement at Special Meeting and Provides Transaction Update

VANCOUVER, British Columbia, Jan. 20, 2022 (GLOBE NEWSWIRE) — Pretium Resources Inc. (TSX/NYSE: PVG) (“Pretivm” or the “Company”) today announced that the Company’s Securityholders (as defined below) approved the previously announced acquisition of Pretivm by Newcrest Mining Limited (ASX/TSX/PNGX: NCM) (“Newcrest”) by way of a plan of arrangement (the “Transaction”) at a special meeting of Securityholders held earlier today (the “Meeting”). The special resolution approving the Transaction was approved by 95.48% of the votes cast by Pretivm’s shareholders and holders of options to acquire shares of the Company (collectively, the “Securityholders”), present virtually or represented by proxy at the Meeting, voting together as a single class. Transaction Details Under the terms of the Transaction, Pretivm shareholders were able to...

Continue reading

Extendicare Announces Timing of 2021 Fourth Quarter Results and Year End Results and Conference Call

MARKHAM, Ontario, Jan. 20, 2022 (GLOBE NEWSWIRE) — Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the fourth quarter and year ended December 31, 2021 after market close on Thursday, February 24, 2022. A conference call hosted by Michael Guerriere, President and Chief Executive Officer and David Bacon, Senior Vice President and Chief Financial Officer, will be held on Friday, February 25, 2022, at 11:30 a.m. (ET) to discuss the results. To participate in the conference call on February 25, 2022, please dial 1-800-319-4610 or 416-915-3239. The conference call and accompanying slide presentation will also be accessible via webcast at www.extendicare.com under the “Our Investors/Events & Presentations” section. A replay of the call will be available...

Continue reading

O2Gold Announces Change of Chief Financial Officer

TORONTO, Jan. 20, 2022 (GLOBE NEWSWIRE) — O2Gold Inc. (TSX-V: OTGO) (“O2Gold” or the “Company”) is pleased to announce that Mr. Ryan Ptolemy has been appointed as the chief financial officer of O2Gold. Mr. Ptolemy is a CPA, CGA and CFA charter holder who also attained a Bachelor of Arts from Western University. Mr. Ptolemy serves as chief financial officer to many public and private companies in the resource sector, particularly development-stage companies. Mr. Ptolemy formerly served as chief financial officer for an independent investment dealer in Toronto where he was responsible for financial reporting, budgeting and the company’s internal controls. The appointment of Mr. Ptolemy follows Ms. Deborah Battiston’s retirement from her role as the chief financial officer of the Company. The board and management of the Company express...

Continue reading

Hubbell Incorporated To Announce Fourth Quarter 2021 Results on February 3, 2022

Shelton, CT, Jan. 20, 2022 (GLOBE NEWSWIRE) — In a release issued earlier on January 20, 2022 by Hubbell Incorporated (NYSE: HUBB), please note that the date of the earnings release has been corrected to February 3, 2022. The corrected release follows:Hubbell Incorporated (NYSE: HUBB) today announced it will release its fourth quarter 2021 financial results prior to the opening of the market on February 3, 2022. The Company will then webcast its Analysts’ Conference Call to discuss the results at 10:00 AM ET. The full text of the press release announcing the results will be posted on Hubbell’s corporate website under the Press Release section. You can also access this information by going to www.hubbell.com and selecting “Investors” from the options at the bottom of the page and then “Press Releases”...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.